Cumberland Pharma (CPIX.US) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Nov5

Cumberland Pharma released FY2025 Q3 earnings on November 4 After-Market EST, actual revenue USD 8.292 M, actual EPS USD -0.1299

00:00

Cumberland Pharma released FY2025 9 Months Earnings on November 4 After-Market EST, with actual revenue of USD 30.84 M and EPS of USD -0.0999

00:00

Oct28

Cumberland Pharma to Release FY2025 Q3 Earnings on November 4 After-Market EST

00:05

Oct1

Cumberland Pharmaceuticals' Injectable Ibuprofen Product Approved by Mexican Regulatory Authority

13:06

Sep29

Tabuk Pharmaceutical Launches Vibativ Antibiotic in Saudi Arabia

13:06

Aug5

Cumberland Pharma released FY2025 Semi-Annual earnings on August 5 After-Market (EST), actual revenue USD 22.55 M, actual EPS USD 0.0338

23:00

Schedules & Filings

Schedules

Filings

Nov4

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 8.292 M, Net Income -1.941 M, EPS -0.1299

Aug5

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 10.84 M, Net Income -740.74 K, EPS -0.05

May6

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 11.71 M, Net Income 1.257 M, EPS 0.08

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More